2010
DOI: 10.1016/j.jnutbio.2009.08.008
|View full text |Cite
|
Sign up to set email alerts
|

Association of MT1A haplotype with cardiovascular disease and antioxidant enzyme defense in elderly Greek population: comparison with an Italian cohort

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
14
0
1

Year Published

2010
2010
2017
2017

Publication Types

Select...
7

Relationship

3
4

Authors

Journals

citations
Cited by 23 publications
(17 citation statements)
references
References 52 publications
2
14
0
1
Order By: Relevance
“…Quality of the analysis was assured by assessment of "quality standard samples" (SERONORM TM TRACE ELEMENT SERUM, Sero AS, Billingstad, Norway). Zn and Cu levels of the quality standard samples were within 10% of the certified levels, as previously reported [10]. Limits of detection estimated with the post-column calibration were 0.5 ppb for 65Cu, 5 ppb for 66Zn.…”
Section: Zinc and Copper Plasma Level Determinationssupporting
confidence: 85%
“…Quality of the analysis was assured by assessment of "quality standard samples" (SERONORM TM TRACE ELEMENT SERUM, Sero AS, Billingstad, Norway). Zn and Cu levels of the quality standard samples were within 10% of the certified levels, as previously reported [10]. Limits of detection estimated with the post-column calibration were 0.5 ppb for 65Cu, 5 ppb for 66Zn.…”
Section: Zinc and Copper Plasma Level Determinationssupporting
confidence: 85%
“…Metallothioneins have been suggested in playing a cardioprotective role by regulating metal homeostasis and anti-oxidant response [4446]. Recently, a human study found that individuals with the MT1A genetic polymorphism are predisposed to developing cardiovascular disease when there is an imbalance between oxidant production and antioxidant defenses [47]. In our study, MT1A was specifically identified in pygmy sperm whales liver.…”
Section: Discussionsupporting
confidence: 51%
“…An association of the +647/+1245 MT1A haplotype in CVDs in a Greek cohort and a modulation of antioxidant enzyme activity suggests a possible reduced antioxidant function of some MT1 variants. Considering these last results, personalized antioxidant treatment could be useful to attenuate the disease progression in subjects with MT variants more susceptible to oxidative stress.…”
Section: Metallothionein and Diabetesmentioning
confidence: 96%
“…Few studies investigate the implication of MT polymorphisms with diabetes ant its cardiovascular and renal complications. +647 A/C and +1245 A/G MT1A SNPs have been related to diabetic complications in Italian and Chinese populations , while +647/+1245 MT1A haplotype have been associated with cardiovascular diseases in Greece . Interestingly, a recent investigation has demonstrated an independent association of MT2A A‐5G polymorphism, in the promoter region affecting MT2A production, with the risks of chronic kidney disease and DM2 in a large Japanese population .…”
Section: Zn Metabolism and Mt Function In Diabetic Nephropathy And Camentioning
confidence: 99%